18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case

Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1252-1253. doi: 10.1007/s00259-020-05011-6. Epub 2020 Sep 2.

Authors

Haiyan Wang¹, Qiaoyi Xue², Zhiwen You¹, Xing Chen¹, Jianmin Yuan², Jun Zhao³

Affiliations

¹ Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
² Central Research Institute, UIH Group, Shanghai, People's Republic of China.
³ Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. [email protected].

PMID: 32876705
DOI: 10.1007/s00259-020-05011-6

No abstract available

Keywords: PET/MR; Treatment response monitoring; Turcot syndrome.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Brain Neoplasms*
Colorectal Neoplasms
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Neoplastic Syndromes, Hereditary*
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18

Supplementary concepts

Turcot syndrome

Grants and funding

PWZzk2017-24/Key Specialty Construction Project of Pudong Health and Family Planning Commission of Shanghai